Figure 6From: Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/mlFour-year biochemical relapse-free survival for pT3-4 and that for pT1-2 in patients who received 64 or 64.8 Gy to the prostate bed.Back to article page